The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry
Monika Žurková (Olomouc, Czech Republic), Monika Zurková, Vítezslav Kolek, Vladimíra Loštáková, Eva Kriegová, Martina Šterclová, Vladimír Bartoš, Martina Doubková, Ilona Binková, Michal Svoboda, Jana Strenková, Martina Placková, Ladislav Lacina, Vladimir Rihak, František Petrík, Pavlína Lisá, Radka Bittenglová, Richard Tyl, Gustav Ondrejka, Hana Suldova, Jaroslav Lnenicka, Jana Pšikalová, Tomáš Snízek, Jirí Homolka, Renata Králova, Jan Kervitzer, Martina Vašáková
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Session: IPF: from pathogenesis to treatment II
Session type: Poster Discussion
Number: 2087
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Monika Žurková (Olomouc, Czech Republic), Monika Zurková, Vítezslav Kolek, Vladimíra Loštáková, Eva Kriegová, Martina Šterclová, Vladimír Bartoš, Martina Doubková, Ilona Binková, Michal Svoboda, Jana Strenková, Martina Placková, Ladislav Lacina, Vladimir Rihak, František Petrík, Pavlína Lisá, Radka Bittenglová, Richard Tyl, Gustav Ondrejka, Hana Suldova, Jaroslav Lnenicka, Jana Pšikalová, Tomáš Snízek, Jirí Homolka, Renata Králova, Jan Kervitzer, Martina Vašáková. The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry. Eur Respir J 2016; 48: Suppl. 60, 2087
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: